0 0 0
This online shop is using cookies to give you the best shopping experience. Thereby for example the session information or language setting are stored on your computer. Without cookies the range of the online shop's functionality is limited. If you do not agree, please click here.

Bolla, van Poppel Management of Prostate Cancer

A Multidisciplinary Approach

ISBN: 978-3-319-42768-3

Edition: 2nd Ed.

Publication date: January 2017

Cover: Hardcover

Pages: 414 p.

Illustrations: 75 ill.

Publisher: Springer

Delivery times, dependent on availability and publisher: between 2 and 14 days from when you complete the order.

Description

  • Provides an exhaustive review of the state of the art in the management of prostate cancer
  • Emphasizes a multidisciplinary approach
  • Explains the roles of the different therapies and active surveillance
  • Addresses diagnosis and clinical work-up in depth
  • Examines the value of individual and mass screening

This book, now in an extensively revised second edition, provides an exhaustive review of the state of the art in the management of prostate cancer, from screening to treatment, with emphasis on a multidisciplinary approach. The editors are very excited about the outstanding new or updated contributions from the different expert authors.

The opening chapters address basic aspects including epidemiology, pathology, biology, genetics, and chemoprevention. The role of individual and mass screening is carefully appraised, and extensive attention is devoted to diagnosis and clinical work-up by means of recently implemented investigations such as multiparametric MRI and choline PET-CT.

The use of active surveillance is examined in detail. Subsequent chapters discuss the different therapies that may be employed: open and minimally invasive, including robot-assisted, radical prostatectomy, the various forms of radiation treatment, high-intensity focused ultrasound, cryotherapy, hormonal manipulations, chemotherapy, targeted therapies, and immunotherapy. Up-to-date results from practice-changing phase III randomized clinical trials are included and special insights are provided into the interpretation of results and the patient’s perspective.